Prevention of cardiovascular risk by moderate alcohol consumption: Epidemiologic evidence and plausible mechanisms

Internal and Emergency Medicine

Volumn 5, Issue 4, 2010, Pages 291-297

  Di Castelnuovo, Augusto ^a   Costanzo, Simona ^a   Donati, Maria Benedetta ^a   Iacoviello, Licia ^a   de Gaetano, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alcohol; Total mortality; Vascular risk; Wine

Indexed keywords

ALCOHOL;

CARDIOVASCULAR DISEASE; DRINKING BEHAVIOR; FEMALE; HUMAN; MALE; REVIEW; RISK ASSESSMENT;

ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; ETHANOL; FEMALE; HUMANS; MALE; RISK ASSESSMENT;

EID: 77955052915     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0346-0     Document Type: Review

References (64)

1. Corrao G, Bagnardi V, Zambon A et al (1999) Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction 94: 1551-1573.
2. Di Castelnuovo A, Rotondo S, Iacoviello L et al (2002) Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105: 2836-2844.
3. Reynolds K, Lewis BL, Nolen JDL et al (2003) Alcohol consumption and risk of stroke: a meta-analysis. JAMA 289: 579-588.
4. Jepson RG, Fowkes FG, Donnan PT et al (1995) Alcohol intake as a risk factor for peripheral arterial disease in the general population in the Edinburgh Artery Study. Eur J Epidemiol 11: 9-14.
5. Vliegenthart R, Geleijnse JM, Hofman A et al (2002) Alcohol consumption and risk of peripheral arterial disease: the Rotterdam study. Am J Epidemiol 155: 332-338.
6. Lichtenstein AH, Appel LJ, Brands M et al (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114: 82-96.
7. Trichopoulou A, Bamia C, Trichopoulos D (2009) Anatomy of health effects of the Mediterranean diet: Greek EPIC prospective cohort study. BMJ 338: b2337.
8. Corrao G, Bagnardi V, Zambon A et al (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38: 613-619.
9. Di Castelnuovo A, Costanzo S, Bagnardi V et al (2006) Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166: 2437-2445.
10. Rehm J, Mathers C, Popova S et al (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373: 2223-2233.
11. Rimm EB, Williams P, Fosher K et al (1999) Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319: 1523-1528.
12. Collins MA, Neafsey EJ, Mukamal KJ et al (2009) Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 33: 206-219.
13. Briel M, Ferreira-Gonzalez I, You JJ et al (2009) Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ 338: b92.
14. Holvoet P, Peeters K, Lund-Katz S et al (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21: 844-848.
15. Corella D, Tucker K, Lahoz C et al (2001) Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 73: 736-745.
16. Femia R, Natali A, L'Abbate A et al (2006) Coronary atherosclerosis and alcohol consumption: angiographic and mortality data. Arterioscler Thromb Vasc Biol 26: 1607-1612.
17. Ruf JC, Jl Berger, Renaud S (1995) Platelet rebound effect of alcohol withdrawal and wine drinking in rats: relation to tannins and lipid peroxidation. Arterioscler Thromb Vasc Biol 1: 140-144.
18. Hendriks HF, van der Gaag MS (1998) Alcohol, coagulation and fibrinolysis. Novartis Found Symp 216: 111-120 (discussion 120-124).
19. Ridker PM, Vaughan DE, Stampfer MJ et al (1994) Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 272: 929-933.
20. Wannamethee SG, Lowe GD, Shaper G et al (2003) The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men. Thromb Haemost 90: 1080-1087.
21. Investigators GISSI-Prevenzione (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455.
22. de Lorgeril M, Salen P, Martin JL et al (2008) Interactions of wine drinking with omega-3 fatty acids in coronary heart disease patients: a fish-like effect of moderate wine drinking. Am Heart J 155: 175-181.
23. di Giuseppe R, de Lorgeril M, Salen P et al (2009) European Collaborative Group of the IMMIDIET Project. Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations. Am J Clin Nutr 89: 354-362.
24. Guiraud A, de Lorgeril M, Boucher F et al (2004) Cardioprotective effect of chronic low dose ethanol drinking: insights into the concept of ethanol preconditioning. J Mol Cell Cardiol 36: 561-566.
25. Krenz M, Cohen MV, Downey JM (2002) The protective and anti-protective effects of ethanol in a myocardial infarct model. Ann N Y Acad Sci 957: 103-114.
26. Toufektsian MC, de Lorgeril M, Nagy N et al (2008) Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemia-reperfusion injury. J Nutr 138: 747-752.
27. Niccoli G, Altamura L, Fabretti A, Lanza GA, Biasucci LM, Rebuzzi AG, Leone AM, Porto I, Burzotta F, Trani C, Crea F (2008) Ethanol abolishes ischemic preconditioning in humans. Am Coll Cardiol 51: 271-275.
28. Soleas GJ, Diamandis EP, Goldberg DM (1997) Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11: 287-313.
29. Guarda E, Godoy I, Foncea R et al (2005) Red wine reduces oxidative stress in patients with acute coronary syndrome. Int J Cardiol 104: 35-38.
30. Tsang C, Higgins S, Duthie GG et al (2005) The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers. Br J Nutr 93: 233-240.
31. Sacanella E, Vázquez-Agell M, Mena MP et al (2007) Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am J Clin Nutr 86: 1463-1469.
32. Estruch R, Sacanella E, Mota F et al (2009) Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: a randomised cross-over trial. Nutr Metab Cardiovasc Dis [Epub ahead of print].
33. De Curtis A, Murzilli S, Di Castelnuovo A et al (2005) Alcohol-free red wine prevents arterial thrombosis in dietary-induced hypercholesterolemic rats: experimental support for the 'French paradox'. J Thromb Haemost 3: 346-350.
34. Di Minno G, Silver JM (1983) Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J Pharmacol Exp Ther 225: 57-60.
35. Pace-Asciak CR, Rounova O, Hahn SE et al (1996) Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 246: 163-182.
36. Rotondo S, Rotilio D, Cerletti C et al (1996) Red wine, aspirin and platelet function. Thromb Haemost 76: 818-819.
37. Rotondo S, Rajtar G, Manarini S et al (1998) Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 123: 1691-1699.
38. Estruch R, Sacanella E, Badia E et al (2004) Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175: 117-123.
39. McKee M, Britton A (1998) The positive relationship between alcohol and heart disease in Eastern Europe: potential physiological mechanisms. J Roy Soc Med 91: 402-407.
40. Feinman L, Lieber C (1999) Ethanol and lipid metabolism. Am J Clin Nutr 70: 791-792.
41. Grønbaek MJ (2009) The positive and negative health effects of alcohol and the public health implications. Intern Med 265: 407-420.
42. Jackson R, Broad J, Connor J et al (2005) Alcohol and ischaemic heart disease: probably no free lunch. Lancet 366: 1911-1912.
43. Naimi TS, Brown DW, Brewer RD et al (2005) Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U. S. adults. Am J Prev Med 28: 369-373.
44. Mukamal KJ, Ding EL, Djoussé L (2006) Alcohol consumption, physical activity, and chronic disease risk factors: a population-based cross-sectional survey. BMC Public Health 6: 118.
45. Pearson TA, Blair SN, Daniels SR et al (2002) AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 106: 388-391.
46. Di Castelnuovo A, Iacoviello L, de Gaetano G (2003) Alcohol and coronary heart disease. N Engl J Med 348: 1719-1722.
47. Gronbaek M, Di Castelnuovo A, Iacoviello L et al (2004) Wine, alcohol and cardiovascular risk: open issue. J Thromb Haemost 2: 2041-2048.
48. Ursini F, Zamburlini A, Cazzolato G et al (1998) Postprandial plasma lipid peroxides: a possible link between diet and atherosclerosis. Free Radic Biol Med 25: 250-252.
49. McElduff P, Dobson AJ (1997) How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ 314: 1159-1164.
50. Kauhanen J, Kaplan GA, Goldberg DE et al (1997) Beer binging and mortality: results from the Kuopio ischaemic heart disease risk factor study: a prospective population based study. BMJ 315: 846-851.
51. Mukamal JK, Conigrave KM, Mittleman MA et al (2003) Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348: 109-118.
52. Mukamal KJ, Ascherio A, Mittleman MA et al (2005) Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann Intern Med 142: 11-19.
53. Iestra JA, Kromhout D, van der Schouw YT et al (2005) Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation 112: 924-934.
54. Janszky I, Ljung R, Ahnve S et al (2008) Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP study. Eur Heart J 29: 45-53.
55. Mukamal KJ (2003) Alcohol use and prognosis in patients with coronary heart disease. Prev Cardiol 6: 93-98.
56. Gronbaek M, Johansen D, Becker U et al (2004) A changes in alcohol intake and mortality: a longitudinal population-based study. Epidemiology 15: 222-228.
57. White IR, Altmann DR, Nanchahal K (2002) Alcohol consumption and mortality: modelling risks for men and women at different ages. BMJ 325: 191.
58. Streppel MT, Ocké MC, Boshuizen HC et al (2009) Long-term wine consumption is related to cardiovascular mortality and life expectancy independently of moderate alcohol intake: the Zutphen Study. J Epidemiol Commun Health 63: 534-540.
59. Djoussé L, Driver JA, Gaziano JM (2009) Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 302: 394-400.
60. Forman JP, Stampfer MJ, Curhan GC (2009) Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 302: 401-411.
61. Koppes LL, Dekker JM, Hendriks HF et al (2005) Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 28: 719-725.
62. Beaglehole R, Bonita R (2009) Alcohol: a global health priority. Lancet 373: 2173-2174.
63. Hines LM, Stampfer MJ, Ma J et al (2001) Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 344: 549-555.
64. Latella MC, Di Castelnuovo A, de Lorgeril M et al (2009) Genetic variation of alcohol dehydrogenase type 1C (ADH1C), alcohol consumption, and metabolic cardiovascular risk factors: results from the IMMIDIET study. Atherosclerosis 207: 284-290.